Display Settings:

Format

Send to:

Choose Destination

    Proc Natl Acad Sci U S A. 2009 Jul 21;106(29):12061-6. Epub 2009 Jul 2.

    Endosomal TLR signaling is required for anti-nucleic acid and rheumatoid factor autoantibodies in lupus.

    Kono DH, Haraldsson MK, Lawson BR, Pollard KM, Koh YT, Du X, Arnold CN, Baccala R, Silverman GJ, Beutler BA, Theofilopoulos AN.

    Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA 92037, USA. dkono@scripps.edu

    Using the Unc93b1 3d mutation that selectively abolishes nucleic acid-binding Toll-like receptor (TLR) (TLR3, -7, -9) signaling, we show these endosomal TLRs are required for optimal production of IgG autoAbs, IgM rheumatoid factor, and other clinical parameters of disease in 2 lupus strains, B6-Fas(lpr) and BXSB. Strikingly, treatment with lipid A, an autoAb-inducing TLR4 agonist, could not overcome this requirement. The 3d mutation slightly reduced complete Freund's adjuvant (CFA)-mediated antigen presentation, but did not affect T-independent type 1 or alum-mediated T-dependent humoral responses or TLR-independent IFN production induced by cytoplasmic nucleic acids. These findings suggest that nucleic acid-sensing TLRs might act as an Achilles' heel in susceptible individuals by providing a critical pathway by which relative tolerance for nucleic acid-containing antigens is breached and systemic autoimmunity ensues. Importantly, this helps provide an explanation for the high frequency of anti-nucleic acid Abs in lupus-like systemic autoimmunity.

    PMID: 19574451 [PubMed - indexed for MEDLINE]

    PMCID: 2715524

    Supplemental Content

    Click here to read Click here to read Click here to read Click here to read